Aignostics

AI pathology at scale

Berlin, New York, Germany

Precision Medicine/Diagnostics AI / ML DiagnosticsSeries B

Aignostics, founded in 2018, develops explainable AI foundation models for digital pathology and computational biomarker discovery. The company is headquartered in Berlin, Germany, with an additional office in New York, United States.

Aignostics hero image

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Aignostics on @MedStartr Today Aignostics, founded in 2018, develops explainable AI foundation models for digital pathology and computational biomarker discovery. The company is headquartered in Berlin, Germany, with an additional office in New York, United States. #AutoimmuneDiseases #DegenerativeDiseases #InfectiousDiseases #MentalBehavioralHealth #CancerOncology #PrecisionMedicineDiagnostics #AIML #Diagnostics #MedMo #MedStartrVentures

https://www.medstartr.ai/s/7dbzNw6uiKQ

Get Involved in Aignostics

1 engagement

How We Help

Problem Statement

Biopharmaceutical companies and pathologists face challenges in analyzing complex multi-modal pathology data to derive transformative insights for drug discovery, diagnostics, and treatment development across various disease areas.

Core Technology

explainable AI foundation models

Key Differentiators

Access to pathology samples and multimodal data from over 30 million patients

Clinical Focus

Tumor Microenvironment Profiling

Company Info

Business Model: B2B
Founded: 2020
Total Funding: Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now
Website: www.aignostics.com/

Disease Areas

Autoimmune Disease Degenerative Diseases Infectious Diseases Mental Health Cancer & Oncology

Technologies

Digital PathologyComputational Biomarker DiscoveryGenerative AIAI & Machine Learning

Clinical & IP

🔬

Clinical Validation

ISO 13485 and ISO 27001 certified. GCP-ready platform. Atlas 2 foundation model (co-developed with Mayo Clinic) ranks #1 across 80 public benchmarks with 2B parameters and 5M+ slide training dataset. Published research in peer-reviewed journals. Research-use only; clinical deployment pathway underway.

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Aignostics?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.